According to the World Health Organization, about one quarter of the world’s population is infected with tuberculosis (TB) bacteria. Only a small proportion of those infected will become sick with TB. People with weakened immune systems have a much greater risk of falling ill from TB. A person living with HIV is about 20 times more likely to develop active tuberculosis.
Life sciences and pharmaceutical companies are dedicated to delivering highly innovative drugs for the treatment of tuberculosis and multidrug-resistant tuberculosis. H1’s turned the lens inward to surface some interesting stats on the number of key opinion leaders (KOLs) and institutions doing work in this area. See how claims data reveals HCPs within specific therapeutic areas.